Regeneron Pharma Q4 Profit Declines; Adj. Total Revenues Up 14%
3/2 13:03
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) reported fourth-quarter adjusted profit per share of $12.56 compared to $23.42, prior year. On average, 21 analysts polled by Thomson Reuters expected the company to report profit per share of $10.03, for the quarter. Analysts' e...